Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to $1.0 million.

  • Cumberland Pharmaceuticals' Depreciation & Amortization (CF) fell 700.98% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 85.64%. This contributed to the annual value of $4.9 million for FY2024, which is 67.65% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) is $1.0 million, which was down 700.98% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) ranged from a high of $1.7 million in Q1 2022 and a low of $511483.0 during Q4 2022
  • In the last 5 years, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $1.2 million in 2023 and averaged $1.2 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) crashed by 5251.39% in 2022 and then soared by 14111.59% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $1.1 million in 2021, then crashed by 52.51% to $511483.0 in 2022, then skyrocketed by 141.12% to $1.2 million in 2023, then rose by 21.34% to $1.5 million in 2024, then tumbled by 30.65% to $1.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.0 million for Q3 2025, versus $1.0 million for Q2 2025 and $1.0 million for Q1 2025.